P&G/Watson Macrobid "Authorized" Generic Launch Prompts Mylan Lawsuit

The practice of a branded company "authorizing" a generic misleads consumers and undercuts Waxman/Hatch incentives, Mylan says. Watson launched its generic one day after Mylan received ANDA approval and began marketing nitrofurantoin under 180 days of exclusivity.